Genmab AS (Denmark) Price on February 26, 2024
| GMAB Stock | DKK 1,526 15.00 0.99% |
If you're considering investing in Genmab Stock, it is important to understand the factors that can impact its price. As of today, the current price of Genmab AS stands at 1,526, as last reported on the 1st of December, with the highest price reaching 1,532 and the lowest price hitting 1,504 during the day. Genmab AS holds Efficiency (Sharpe) Ratio of -0.2, which attests that the entity had a -0.2% return per unit of risk over the last 3 months. Genmab AS exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Genmab AS's Market Risk Adjusted Performance of (0.47), risk adjusted performance of (0.15), and Standard Deviation of 1.5 to validate the risk estimate we provide.
Genmab Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Genmab |
Sharpe Ratio = -0.1976
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | GMAB |
Estimated Market Risk
| 1.5 actual daily | 13 87% of assets are more volatile |
Expected Return
| -0.3 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.2 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Genmab AS is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Genmab AS by adding Genmab AS to a well-diversified portfolio.
Genmab AS Valuation on February 26, 2024
It is possible to determine the worth of Genmab AS on a given historical date. On February 26, 2024 Genmab was worth 2013.0 at the beginning of the trading date compared to the closed value of 2007.0. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Genmab AS stock. Still, in general, we apply an absolute valuation method to find Genmab AS's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Genmab AS where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Genmab AS's related companies.
| Open | High | Low | Close | Volume | |
| 2,000 | 2,019 | 1,992 | 2,013 | 109,428 | |
02/26/2024 | 2,013 | 2,033 | 2,001 | 2,007 | 93,765 |
| 2,008 | 2,015 | 1,969 | 1,988 | 107,715 |
| Backtest Genmab AS | | | Genmab AS History | | | Genmab AS Valuation | Previous | Next |
Genmab AS Trading Date Momentum on February 26, 2024
| On February 27 2024 Genmab AS was traded for 1,988 at the closing time. The highest price during the trading period was 2,015 and the lowest recorded bid was listed for 1,969 . The volume for the day was 107.7 K. This history from February 27, 2024 contributed to the next trading day price decline. The overall trading delta to the next closing price was 0.92% . The overall trading delta to the current price is 1.87% . |
Genmab AS Fundamentals Correlations and Trends
By evaluating Genmab AS's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Genmab AS's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Genmab financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Genmab AS Stock history
Genmab AS investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Genmab is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Genmab AS will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Genmab AS stock prices may prove useful in developing a viable investing in Genmab AS
Genmab AS develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. Genmab AS was founded in 1999 and is headquartered in Copenhagen, Denmark. Genmab AS is traded on Copenhagen Stock Exchange in Denmark.
Genmab AS Stock Technical Analysis
Genmab AS technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Genmab AS Period Price Range
Low | December 1, 2024
| High |
0.00 | 0.00 |
Genmab AS cannot be verified against its exchange. Please verify the symbol is currently traded on Copenhagen Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Genmab AS December 1, 2024 Market Strength
Market strength indicators help investors to evaluate how Genmab AS stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Genmab AS shares will generate the highest return on investment. By undertsting and applying Genmab AS stock market strength indicators, traders can identify Genmab AS entry and exit signals to maximize returns
Genmab AS Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Genmab AS's price direction in advance. Along with the technical and fundamental analysis of Genmab Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Genmab to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.15) | |||
| Jensen Alpha | (0.39) | |||
| Total Risk Alpha | (0.56) | |||
| Treynor Ratio | (0.48) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Information and Resources on Investing in Genmab Stock
When determining whether Genmab AS offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Genmab AS's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Genmab As Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Genmab As Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genmab AS. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Genmab Stock, please use our How to Invest in Genmab AS guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.